713
Participants
Start Date
April 30, 2003
Primary Completion Date
January 31, 2005
Study Completion Date
January 31, 2005
tezosentan
tezosentan delivered i.v. at 20 mL/h (5 mg/h) for 30 min followed by 4 mL/h (1 mg/h) for 23.5 to 71.5 h (24 to 72 h in total)
placebo
Oracle Research, Huntsville
USC Medical Center, Los Angeles
Jacksonville Center for Clinical Research, Jacksonville
University of Miami-Jackson Memorial Hospital, Miami
University Hospital, Augusta
University of Iowa Hospital and Clinics, Iowa City
Medical Research Institute, Slidell
Baystate Medical Center-Cardiology Section, Springfield
Elmhurst Hospital Center, Elmhurst
Columbia Presbyterian Medical Center-Heart Failure Center, New York
New York University School of Medicine, New York
University of North Carolina, Chapel Hill
Duke University Medical Center, Durham
LeBauer Cardiovascular Research Foundation, Greensboro
Baylor College of Medicine - Texas Medical Center, Houston
University of Texas, MD Anderson Cancer Center, Houston
Alfred Hospital, Monash University, Central and Eastern School, Prahran
Concord Repatriation Hospital, Concord NSW
Queen Elizabeth Hospital, Woodville SA
Faculty Hospital St. Anna, Brno
Klinika Kardiologie IKEM, Prague
University Hospital Vinohrady (FNKV), Prague
Masaryk Hospital, Ústí nad Labem
Universitatsklinikum der Humboldt-Universitat Berlin, Campus Charite Mitte, Med. Klinik und Poliklinik, Kardiologie, Berlin
Universitat Greifswald, Klinik fur Innere Medizin B, Greifswald
Asklepios Klinik Langen, Abteilung fur Innere Medizin, Langen
Universitatsklinikum Schleswig Holstein, Medizinische Klinik II, Kardiologie, Lübeck
Klinik u. Poliklinik F. Inn. Med. II, Univ. Klinik Regensburg, Regensburg
Jahn Ferenc, Delpesti Korhaz, Budapest
Polyclinic of the Hospitaler Brothers of St. John of God, Budapest
University of Debrecen, Debrecen
2nd Department of Medicine & Cardiology Centre, Szeged
Cattedra di Cardiologia, c/o Spedali Civili, Brescia
Istituto Clinico Humanitas, U.O. Cardiologia Clin. E Insuff. Cardiaca, Rozzano (MI)
Sentralsykehuset i More og Romsdal, Dept. of Cardiology, Ålesund
Aker University Hospital, Div. Cardiology, Oslo
Central Hospital in Rogaland, Cardiology Division, Stavanger
University Department of Medicine, City Hospital, Birmingham
Cardiology Department, Bridlington & District Hospital, Bridlington
University of Glasgow West, Glasgow
Dept. of Medicine & Therapeutics, University of Leicester, Leicester
Krajska Nemocnice Liberec, Liberec
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
INDUSTRY